60 results
Page 3 of 3
8-K
EX-99.1
wpxoi24 6gt4zb3id3l0
9 Sep 20
Other Events
5:23pm
8-K
EX-99.2
izchwhb ilmjft
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
chduc6
15 Jun 20
Regulation FD Disclosure
7:21am
8-K
EX-1.1
h9tvh7tmn3jv6mq4h2d
12 May 20
Entry into a Material Definitive Agreement
5:14pm
424B5
7ozhkb7xn4382d2 i8b
12 May 20
Prospectus supplement for primary offering
5:02pm
424B5
ra24k0tplkqp1el
11 May 20
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.2
9zlxr3hkg tk
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am
S-3
EX-1.2
jpduca9ylnrl l5389
4 Oct 19
Shelf registration
4:06pm
DEF 14A
wliozwmr rlsjz
26 Apr 19
Definitive proxy
12:00am
10-K
xz40uw0st0
1 Apr 19
Annual report
12:00am
10-Q
o5nkick24
14 Nov 18
Quarterly report
12:00am
DRS/A
7cfom
10 Jul 18
Draft registration statement (amended)
12:00am
DRS
EX-10.9
gl26eqiupk0wgcj
1 Jun 18
Draft registration statement
12:00am
DRS
xftqkom2rbr3pdo
1 Jun 18
Draft registration statement
12:00am